Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Unapproved prescription cough, cold, and allergy medications.
Lee CE, Ostroff C, McMeekin J, Shepperson S, Deveau I.
Chest. 2011 Dec;140(6):1672-3; author reply 1673. No abstract available.
Related citations
Procalcitonin vs clinical and chest film findings to diagnose community-acquired pneumonia in patients with acute asthma or acute exacerbations of chronic bronchitis.
Cunha BA.
Chest. 2011 Dec;140(6):1667-8; author reply 1668. No abstract available.
Serum procalcitonin and infective exacerbations of asthma.
D'silva L, Hassan N, Nair P.
Chest. 2011 Nov;140(5):1389-90; author reply 1390-1. No abstract available.
Childhood asthma: the need for a personalized "whole child" approach.
Cicutto L.
Chest. 2011 Nov;140(5):1108-10. No abstract available.
Role of CXCL13 in asthma: novel therapeutic target.
Baay-Guzman GJ, Huerta-Yepez S, Vega MI, Aguilar-Leon D, Campillos M, Blake J, Benes V, Hernandez-Pando R, Teran LM.
Chest. 2012 Apr;141(4):886-94. Epub 2011 Oct 20.
Why conventional exhaled breath condensate pH studies cannot provide reliable estimates of airway acidification.
Effros RM, Casaburi R, Porszasz J, Rehan V.
Chest. 2011 Oct;140(4):1099. No abstract available.
Recurrent sepsis in a 69-year-old woman.
Konduru S, Koussa G, Naber M, Beegle S.
Chest. 2011 Oct;140(4):1091-4. No abstract available.
Asthma unmasked with tumor necrosis factor-α-blocking drugs.
Guilleminault L, Carré P, Beau-Salinas F, Taillé C, Dieudé P, Crestani B, Diot P, Marchand-Adam S.
Chest. 2011 Oct;140(4):1068-71.
New kids on the block: the emerging role of apolipoproteins in the pathogenesis and treatment of asthma.
Yao X, Remaley AT, Levine SJ.
Chest. 2011 Oct;140(4):1048-54.
Flavocoxid and hypersensitivity pneumonitis.
Levy RM.
Chest. 2011 Sep;140(3):827-8; author reply 828. No abstract available.
Evidence incorporating patients' values.
Kim KH, Kang JW, Kim TH, Lee MS.
Chest. 2011 Sep;140(3):831-2; author reply 832. No abstract available.
The many faces of Merlin: IgG4-associated pulmonary-renal disease.
Sprangers B, Lioen P, Meijers B, Lerut E, Meersschaert J, Blockmans D, Claes K.
Chest. 2011 Sep;140(3):791-4.
Aerosol therapy for obstructive lung diseases: device selection and practice management issues.
Sims MW.
Chest. 2011 Sep;140(3):781-8. Review.
Alternatively activated macrophages and airway disease.
Byers DE, Holtzman MJ.
Chest. 2011 Sep;140(3):768-74. Review.
Counterpoint: efficacy of bronchial thermoplasty for patients with severe asthma. Is there sufficient evidence? Not yet.
Michaud G, Ernst A.
Chest. 2011 Sep;140(3):576-7; discussion 577. No abstract available.
Point: efficacy of bronchial thermoplasty for patients with severe asthma. Is there sufficient evidence? Yes.
Shifren A, Chen A, Castro M.
Chest. 2011 Sep;140(3):573-5; discussion 578. No abstract available.
Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
Ostroff C, Lee CE, McMeekin J.
Chest. 2011 Aug;140(2):295-300.
Is the inflammatory response of the lungs in COPD abnormal?
Siafakas NM, Tzortzaki EG.
Chest. 2011 Aug;140(2):561-2; author reply 562. No abstract available.
Managing cough in the aftermath of the decision of the US Food and Drug Administration to remove unapproved prescription cough medications from the market.
Irwin RS, Smith BS.
Chest. 2011 Aug;140(2):282-4. No abstract available.
Do sex and atopy influence cough outcome measurements in children?
Chang AB, Gibson PG, Willis C, Petsky HL, Widdicombe JG, Masters IB, Robertson CF.
Chest. 2011 Aug;140(2):324-30. Epub 2011 Mar 10.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on